Nebulized Bacterioruberin/Astaxanthin-Loaded Nanovesicles: Antitumoral Activity and Beyond
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178607 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Victoria Rebeca Dana González Epelboim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nanomedicine Research and Development Centre (NARD), Science and Technology Department, National University of Quilmes, Roque Saenz Peña 352, Bernal …. Hauptthemen laut MEDLINE: Nanoparticles, Carotenoids, Xanthophylls, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CONICET, Secretaria de Investigaciones, Universidad Nacional de Quilmes.
Abstract (Originalsprache)
The membranes of halophilic archaea are a source of novel biomaterials, mainly of isoprenoid nature, with therapeutic properties practically unraveled. Here, we explored the antitumoral activity of neutral archaeolipids (NAs, such as bacterioruberin, astaxanthin, and dihydrosqualene) present in the total archaeolipids (TAs) (a fraction from the first step of lipid extraction by the modified Blight and Dyer technique) extracted from halophilic archaea Halorubrum tebenquichense, and formulated as TA-nanoarchaeosomes (TA: polar archaeolipids (PAs): Tween 80, 5:5:4 w:w:w, TA-nanoARC). The structure of 300.3 ± 84.2 nm TA-nanoARC of 0.59 ± 0.12 polydispersity index and −20 ± 3.7 mV ζ potential as determined by SAXS modelling, revealed that NA reduced the hydrophobic core and enlarged its hydrophilic section in comparison to TA-lacking bilayers (nanoARC), while preserving the width (~50 Å) and unilamellarity. Stable to storage and nebulization, TA-nanoARC was cytotoxic on A549 cells after 48 h, with an IC50 expressed as [bacterioruberin] of 0.15 μg/mL (~0.20 µM), comparable to or lower than the IC50 of docetaxel or cisplatin. Such cytotoxicity was exerted at a concentration harmless to macrophages (mTHP-1 cells). Besides, the conditioned medium from TA-nanoARC nebulized on A549 cells reduced the expression of the CD204/SRA-1, an M2 phenotype marker, and induced pro-inflammatory activity, comparable to or to a greater extent than that induced by lipopolysaccharide, including IL-6 and TNF-α, in mTHP-1 as a model of tumor-associated macrophages. The endocytosis of TA-nanoARC by A549 cells induced Lysotracker red fluorescence to fade and blur. This suggested the internalization of the highly viscous and ordered TA-nanoARC rich in NAs and subsequent lysosomal dysfunction (and not its antioxidant activity), as responsible for the selective damage on A549 cells. These are the first results showing that nebulized TA-nanoARC, lethal to A549 cells and modulating mTHP-1 cell phenotype, may act as antitumorals in the absence of cytotoxic drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanomedicine Research and Development Centre (NARD), Science and Technology Department, National University of Quilmes, Roque Saenz Peña 352, Bernal 1876, Buenos Aires, Argentina.
- Laboratorio de Cristalografía Aplicada (LCA), Instituto de Tecnologías Emergentes y Ciencias Aplicadas (ITECA), Escuela de Ciencia y Tecnología (ECyT), UNSAM-CONICET, Campus Miguelete, San Martín 1650, Buenos Aires, Arg…
- ALBA Synchrotron Light Source, Carrer de la Llum 2-26, Cerdanyola del Vallès, 08290 Barcelona, Spain.
- Department of Pharmaceutical Technology, Jadavpur University, 188, Raja Subodh Chandra Mallick Rd., Jadavpur, Kolkata 700032, West Bengal, India.
ORCID-Profile: Victoria Rebeca Dana González Epelboim, Diego G Lamas, Cristián Huck-Iriart, Ezequiel Nicolas Caputo, Maria Julia Altube, Horacio Emanuel Jerez, Kajal Ghosal, Leticia Herminia Higa, Eder Lilia Romero
Förderung
- CONICET
- Secretaria de Investigaciones, Universidad Nacional de Quilmes
Zitieren
APA
González Epelboim, V. R. D., Lamas, D. G., Huck-Iriart, C., Caputo, E. N., Altube, M. J., Jerez, H. E., Simioni, Y. R., Ghosal, K., Morilla, M. J., Higa, L. H., & Romero, E. L. (2025). Nebulized Bacterioruberin/Astaxanthin-Loaded Nanovesicles: Antitumoral Activity and Beyond. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178607
Vancouver
González Epelboim VRD, Lamas DG, Huck-Iriart C, Caputo EN, Altube MJ, Jerez HE, et al. Nebulized Bacterioruberin/Astaxanthin-Loaded Nanovesicles: Antitumoral Activity and Beyond. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178607
BibTeX
@article{GonzlezEpelboim2025,
author = {González Epelboim, Victoria Rebeca Dana and Lamas, Diego G and Huck-Iriart, Cristián and Caputo, Ezequiel Nicolas and Altube, Maria Julia and Jerez, Horacio Emanuel and Simioni, Yamila Roxana and Ghosal, Kajal and Morilla, Maria Jose and Higa, Leticia Herminia and Romero, Eder Lilia},
title = {Nebulized Bacterioruberin/Astaxanthin-Loaded Nanovesicles: Antitumoral Activity and Beyond},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178607}
}
EUVIMED